9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Monitoring, documenting and reporting the quality of antibiotic use in the Netherlands: a pilot study to establish a national antimicrobial stewardship registry

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The Dutch Working Party on Antibiotic Policy is developing a national antimicrobial stewardship registry. This registry will report both the quality of antibiotic use in hospitals in the Netherlands and the stewardship activities employed. It is currently unclear which aspects of the quality of antibiotic use are monitored by antimicrobial stewardship teams (A-teams) and can be used as indicators for the stewardship registry. In this pilot study we aimed to determine which stewardship objectives are eligible for the envisioned registry.

          Methods

          We performed an observational pilot study among five Dutch hospitals. We assessed which of the 14 validated stewardship objectives (11 process of care recommendations and 3 structure of care recommendations) the A-teams monitored and documented in individual patients. They provided, where possible, data to compute quality indicator (QI) performance scores in line with recently developed QIs to measure appropriate antibiotic use in hospitalized adults for the period of January 2015 through December 2015

          Results

          All hospitals had a local antibiotic guideline describing recommended antimicrobial use. All A-teams monitored the performance of bedside consultations in Staphylococcus aureus bacteremia and the prescription of restricted antimicrobials. Documentation and reporting were the best for the use of restricted antimicrobials: 80% of the A-teams could report data. Lack of time and the absence of an electronic medical record system enabling documentation during the daily work flow were the main barriers hindering documentation and reporting.

          Conclusions

          Five out of 11 stewardship objectives were actively monitored by A-teams. Without extra effort, 4 A-teams could report on the quality of use of restricted antibiotics. Therefore, this aspect of antibiotic use should be the starting point of the national antimicrobial stewardship registry. Our registry is expected to become a powerful tool to evaluate progress and impact of antimicrobial stewardship programs in hospitals.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: not found
          • Article: not found

          The Quality of Care

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

            Antimicrobial resistance (AMR) is now a global threat. Its emergence rests on antimicrobial overuse in humans and food-producing animals; globalization and suboptimal infection control facilitate its spread. While aggressive measures in some countries have led to the containment of some resistant gram-positive organisms, extensively resistant gram-negative organisms such as carbapenem-resistant enterobacteriaceae and pan-resistant Acinetobacter spp. continue their rapid spread. Antimicrobial conservation/stewardship programs have seen some measure of success in reducing antimicrobial overuse in humans, but their reach is limited to acute-care settings in high-income countries. Outside the European Union, there is scant or no oversight of antimicrobial administration to food-producing animals, while evidence mounts that this administration leads directly to resistant human infections. Both horizontal and vertical infection control measures can interrupt transmission among humans, but many of these are costly and essentially limited to high-income countries as well. Novel antimicrobials are urgently needed; in recent decades pharmaceutical companies have largely abandoned antimicrobial discovery and development given their high costs and low yield. Against this backdrop, international and cross-disciplinary collaboration appears to be taking root in earnest, although specific strategies still need defining. Educational programs targeting both antimicrobial prescribers and consumers must be further developed and supported. The general public must continue to be made aware of the current scale of AMR’s threat, and must perceive antimicrobials as they are: a non-renewable and endangered resource.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quality indicators to measure appropriate antibiotic use in hospitalized adults.

              An important requirement for an effective antibiotic stewardship program is the ability to measure appropriateness of antibiotic use. The aim of this study was to develop quality indicators (QIs) that can be used to measure appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized adult patients.
                Bookmark

                Author and article information

                Contributors
                + 31 (0)24-3619825 , marvin.berrevoets@radboudumc.nl
                jaap.tenoever@radboudumc.nl
                t.sprong@cwz.nl
                r.m.vanhest@amc.uva.nl
                I.Groothuis@mcgroep.com
                ivanheijl@tergooi.nl
                j.schouten@cwz.nl
                marlies.hulscher@radboudumc.nl
                bj.kullberg@radboudumc.nl
                Journal
                BMC Infect Dis
                BMC Infect. Dis
                BMC Infectious Diseases
                BioMed Central (London )
                1471-2334
                15 August 2017
                15 August 2017
                2017
                : 17
                : 565
                Affiliations
                [1 ]ISNI 0000 0004 0444 9382, GRID grid.10417.33, Department of Internal Medicine, Division of Infectious Diseases, , Radboud university medical center, ; Nijmegen, The Netherlands
                [2 ]ISNI 0000 0004 0444 9008, GRID grid.413327.0, Department of Internal Medicine, Division of Infectious Diseases, , Canisius Wilhelmina Hospital, ; Nijmegen, The Netherlands
                [3 ]ISNI 0000000404654431, GRID grid.5650.6, Department of Hospital Pharmacy & Clinical Pharmacology, , Academic Medical Center, ; Amsterdam, The Netherlands
                [4 ]ISNI 0000000404654431, GRID grid.5650.6, , Department of Internal Medicine, Zuiderzee Medical Center, ; Lelystad, The Netherlands
                [5 ]Department of Clinical Pharmacy, Tergooi Hospital, Hilversum, The Netherlands
                [6 ]ISNI 0000 0004 0444 9382, GRID grid.10417.33, Scientific Institute for Quality of Healthcare, , Radboud university medical center, ; Nijmegen, The Netherlands
                [7 ]ISNI 0000 0004 0444 9382, GRID grid.10417.33, Radboud Center for Infectious Diseases, , Radboud university medical center, ; Nijmegen, The Netherlands
                Author information
                http://orcid.org/0000-0001-8333-277X
                Article
                2673
                10.1186/s12879-017-2673-5
                5557571
                28806902
                c56e6f53-fb2e-4712-aad1-414a79ac3f36
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 19 May 2017
                : 8 August 2017
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2017

                Infectious disease & Microbiology
                antibiotic stewardship,quality indicator,benchmarking,antimicrobial stewardship team,antimicrobial stewardship program,quality of care

                Comments

                Comment on this article